Muga R - Search Results

1

Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART.

Lumbreras B, Jarrín I, del Amo J, Pérez-Hoyos S, Muga R, García-de la Hera M, Ferreros I, Sanvisens A, Hurtado I, Hernández-Aguado I. Lumbreras B, et al. Among authors: muga r. AIDS. 2006 Jan 2;20(1):111-6. doi: 10.1097/01.aids.0000196164.71388.3b. AIDS. 2006. PMID: 16327326

2

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.

Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O, Brettle R, del Romero J, Prins M, van Benthem B, Kirk O, Pederson C, Hernández Aguado I, Pérez-Hoyos S, Eskild A, Bruun JN, Sannes M, Sabin C, Lee C, Johnson AM, Phillips AN, Francioli P, Vanhems P, Egger M, Rickenbach M, Cooper D, Kaldor J, Ashton L, Vizzard J, Muga R, Day NE, De Angelis D; CASCADE Collaboration. Babiker A, et al. Among authors: muga r. Int J Epidemiol. 2002 Oct;31(5):951-8. doi: 10.1093/ije/31.5.951. Int J Epidemiol. 2002. PMID: 12435766 Free PMC article.

3

Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category.

Pérez-Hoyos S, del Amo J, Muga R, del Romero J, García de Olalla P, Guerrero R, Hernàndez-Aguado I; GEMES (Spanish Multicenter Study Group of Seroconverters). Pérez-Hoyos S, et al. Among authors: muga r. AIDS. 2003 Feb 14;17(3):353-9. doi: 10.1097/00002030-200302140-00009. AIDS. 2003. PMID: 12556689

4

Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.

García de la Hera M, Ferreros I, del Amo J, García de Olalla P, Pérez Hoyos S, Muga R, del Romero J, Guerrero R, Hernández-Aguado I; GEMES. García de la Hera M, et al. Among authors: muga r. J Epidemiol Community Health. 2004 Nov;58(11):944-50. doi: 10.1136/jech.2003.017475. J Epidemiol Community Health. 2004. PMID: 15483312 Free PMC article.

5

Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.

Pérez-Hoyos S, Ferreros I, del Amo J, Muga R, del Romero J, de Olalla PG, Hernández-Aguado I. Pérez-Hoyos S, et al. Among authors: muga r. AIDS. 2006 Jan 9;20(2):289-91. doi: 10.1097/01.aids.0000202651.41397.db. AIDS. 2006. PMID: 16511426

6

Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001.

Muga R, Sanvisens A, Bolao F, Tor J, Santesmases J, Pujol R, Tural C, Langohr K, Rey-Joly C, Muñoz A. Muga R, et al. Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S29-33. doi: 10.1016/s0376-8716(06)80005-0. Drug Alcohol Depend. 2006. PMID: 16769442

7

Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.

Muga R, Langohr K, Tor J, Sanvisens A, Serra I, Rey-Joly C, Muñoz A. Muga R, et al. Clin Infect Dis. 2007 Aug 1;45(3):370-6. doi: 10.1086/519385. Epub 2007 Jun 19. Clin Infect Dis. 2007. PMID: 17599317 Free article.

8

Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.

Muga R, Ferreros I, Langohr K, de Olalla PG, Del Romero J, Quintana M, Alastrue I, Belda J, Tor J, Pérez-Hoyos S, Del Amo J; Spanish Multicenter Study Group of Seroconverters (GEMES). Muga R, et al. AIDS. 2007 Nov 30;21(18):2521-7. doi: 10.1097/QAD.0b013e3282f1c933. AIDS. 2007. PMID: 18025889

9

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K; CASCADE Collaboration. Bhaskaran K, et al. JAMA. 2008 Jul 2;300(1):51-9. doi: 10.1001/jama.300.1.51. JAMA. 2008. PMID: 18594040

10

Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.

Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, Hernández-Aguado I, Meyer L, Porter K, del Amo J; CASCADE Collaboration. Jarrin I, et al. Among authors: muga r. Am J Epidemiol. 2008 Sep 1;168(5):532-40. doi: 10.1093/aje/kwn179. Epub 2008 Jul 28. Am J Epidemiol. 2008. PMID: 18663213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters